Pharmaceuticals company Procter & Gamble Health announced Q2FY25 results The Company reported sales of Rs 304 crore, flat versus a year ago. The Profit After Tax (PAT) for the quarter was Rs 91 crore, up 26% versus a year ago. Profit After Tax (PAT) was up 13% versus a year ago. The Board has declared an interim dividend of Rs 80 per equity share for the FY25. The record date for the dividend will be February 21, 2025. Milind Thatte, Managing Director, P&G; Health India, said: “This quarter was a period of strategic reinforcement as we took proactive steps to strengthen our supply network. We remain committed to our integrated growth strategy of a focused product portfolio, superiority, productivity, constructive disruption, and an agile and accountable organization structure. We are confident that this strategy will enable us to meet the evolving needs of our consumers and healthcare professionals alike.” Result PDF